SELECT A TYPE OF CANCER
ADVANCED LUNG CANCER
NON-SMALL CELL LUNG CANCER
How do OPDIVO® (nivolumab) and YERVOY® (ipilimumab) team up to fight cancer differently than chemotherapy?
OPDIVO + YERVOY works by helping your immune system to fight cancer. It does this by combining 2 immunotherapy medications that work in different but complementary ways.
Together, OPDIVO and YERVOY can help your immune system launch a response against cancer that's greater than when either medication is used alone.
LIBTAYO is indicated for the first-line treatment of patients with non–small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (tumor proportion score [TPS] ≥50%) as determined by an FDA-approved test, with no EGFR, ALK, or ROS1 aberrations, and is locally advanced where patients are not candidates for surgical resection or definitive chemoradiation OR metastatic.
LIBTAYO is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally
IMFINZI is a prescription medicine used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC). IMFINZI may be used when your NSCLC has not spread outside your chest, cannot be removed by surgery, and has responded or stabilized with initial treatment with chemotherapy that contains platinum, given at the same time as radiation therapy.
LENVIMA® (lenvatinib) is a prescription medicine that is used to treat people with certain kinds of cancer.
TECENTRIQ MAY WORK WITH YOUR IMMUNE SYSTEM TO FIGHT CANCER
PLEASE SELECT CANCER TYPE:
TRODELVY® (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with:
A new era in the treatment of people with HR+, HER2–, node-positive, early breast cancer with a high risk of coming back, or certain types of HR+, HER2– metastatic breast cancer
LYNPARZA is the only PARP inhibitor approved for the following 4 types of advanced cancer:
For use in select patients:
ADVANCED OVARIAN CANCERMETASTATIC PROSTATE CANCERMETASTATIC PANCREATIC CANCERMETASTATIC BREAST CANCER
VENCLEXTA is a prescription medicine used:
IMBRUVICA® (ibrutinib) is a prescription medicine used to treat adults with:
In a clinical study, CABOMETYX was given to people with advanced kidney cancer as a first treatment (your doctor may call it “first-line treatment”), with another medicine, OPDIVO
CABOMETYX is a prescription medicine used to treat:
XTANDI is a prescription medicine used to treat men with prostate cancer that:
CALQUENCE is a prescription medicine used to treat adults with mantle cell lymphoma (MCL) who have received at least one prior treatment for their cancer, or adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
XALKORI® (crizotinib) is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1
ZEJULA is a prescription medicine used for the:
TUKYSA is a prescription medicine used with the medicines trastuzumab and capecitabine to treat adults with human epidermal growth factor receptor-2 (HER2) positive breast cancer that has spread to other parts of the body such as the brain (metastatic), or that cannot be removed by surgery, and who have received one or more anti-HER2 breast cancer treatments.
It is not known if TUKYSA is safe and effective in children.
WHAT IS PADCEV®?
PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. PADCEV may be used if you:
• have received an immunotherapy medicine and chemotherapy that contains platinum, or
• you are not able to receive a chemotherapy that contains the medicine cisplatin and you have received one or more prior therapy.
It is not known if PADCEV is safe and effective in
ENHERTU (en-HER-too) is a prescription medicine used in adults to treat human epidermal growth factor receptor 2 (HER2)-positive:
YESCARTA is a treatment for your large B-cell lymphoma or follicular lymphoma, two types of non-Hodgkin lymphoma. It is used when at least two other kinds of treatment have failed to control your cancer. YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.
BREYANZI is for the treatment of large B-cell lymphoma in patients when at least 2 previous treatments have not worked or have stopped working. BREYANZI is a medicine made from your own white blood cells; the cells are genetically modified to recognize and attack your lymphoma cells.
Metastatic Merkel cell carcinoma (MCC)
First-line maintenance treatment of urothelial carcinoma (UC)
BRUKINSA is a prescription medicine used to treat adults with:
RETEVMO is a prescription medicine that is used to treat certain cancers caused by an abnormal gene, called RET, in:
RYBREVANT® is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that:
SARCLISA is a prescription medicine used in combination with:
What is KYMRIAH?
KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients up to 25 years old who have acute lymphoblastic leukemia (ALL) that is either relapsing (went into remission, then came back) or is refractory (did not go into remission after receiving other leukemia treatments). It is also used in patients with non-Hodgkin lymphoma that has relapsed or is refractory after having at least two other kinds of treatment.
XARELTO® is a prescription medicine used to:
BiotecNOVA meds have completed proven and successful clinical trials
What is FARXIGA?
FARXIGA is a prescription medicine used to:
BiotecNOVA meds have completed proven and successful clinical trials
Copyright © 2018 seeking biotech alpha - All Rights Reserved. City Photos from Pixabay
Powered by GoDaddy Website Builder